hydrocodone bitartrate and acetaminophen tablet
INDICATIONS AND USAGE Hydrocodone bitartrate and acetaminophen tablets are indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. Limitations of Use Because of the risks of addiction, abuse, and misuse, with opioids, even at recommended doses [see WARNINGS ] , reserve Hydrocodone Bitartrate and Acetaminophen Tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics): have not been tolerated, or are not expected to be tolerated, have not provided adequate analgesia, or are not expected to provide adequate analgesia
novel laboratories, inc.
CAPSULE WHITE N 356 5
N 356 5 CAPSULE WHITE
Related Pills
hydrocodone bitartrate and acetaminophen tablet
novel laboratories, inc.
hydrocodone bitartrate and acetaminophen tablet
novel laboratories, inc.
hydrocodone bitartrate and acetaminophen tablet
novel laboratories, inc.
hydrocodone bitartrate and acetaminophen tablet
novel laboratories, inc.
hydrocodone bitartrate and acetaminophen tablet
novel laboratories, inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets, USP 5 mg/325 mg are available as white, capsule-shaped, bisected tablets, debossed "n" and "356" on the scored side and "5" on the other side. They are supplied as follows: Bottles of 30 40032-356-03 Bottles of 100 40032-356-01 Bottles of 500 40032-356-05 Bottles of 1000 40032-356-10
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets USP, 7.5 mg/325 mg are available as white, capsule-shaped, bisected tablets, debossed "n" and "357" on the scored side and "7.5" on the other side. They are supplied as follows: Bottles of 30 40032-357-03 Bottles of 100 40032-357-01 Bottles of 500 40032-357-05 Bottles of 1000 40032-357-10
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets USP, 10 mg/325 mg are available as white, capsule-shaped, bisected tablets, debossed "n" and "358" on the scored side and "10" on the other side. They are supplied as follows: Bottles of 30 40032-358-03 Bottles of 100 40032-358-01 Bottles of 500 40032-358-05 Bottles of 1000 40032-358-10 Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP with a child-resistant closure. Store
HYDROCODONE BITARTRATE AND ACETAMINOPHEN Tablets securely and dispose of properly.[see PRECAUTIONS/ Information for Patients ] Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 PI3530000109 Revised 09/2019
More pills like CAPSULE N 356 5